globenewswire

Laguna Hills Chiropractor Joins Precision Spinal Care

Print E-mail
By GLOBE NEWSWIRE   
Sunday, 01 February 2015 04:00

LAGUNA HILLS, Calif., Feb. 1, 2015 (GLOBE NEWSWIRE)

Read more...
 

Dr. Jennifer Lavallee, Cat Veterinarian, to Speak at 87th Annual Western Veterinary Conference

Print E-mail
By GLOBE NEWSWIRE   
Sunday, 01 February 2015 04:00

CASTLE ROCK, Colo., Feb. 1, 2015 (GLOBE NEWSWIRE)

Read more...
 

Oxnard Dentist Stresses Importance of Dental Care in 2015

Print E-mail
By GLOBE NEWSWIRE   
Sunday, 01 February 2015 04:00

OXNARD, Calif., Feb. 1, 2015 (GLOBE NEWSWIRE)

Read more...
 

Early Detection and Treatment Key to Sciatica Pain Relief, Says Atlanta Chiropractor

Print E-mail
By GLOBE NEWSWIRE   
Sunday, 01 February 2015 02:00

ATLANTA, Feb. 1, 2015 (GLOBE NEWSWIRE)

Read more...
 

Chimerix Focusing Efforts on CMV and Adenovirus Pivotal Trials

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 12:12

DURHAM, N.C.--Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that after discussion with the U.S. Food and Drug Administration, the company is ceasing further participation in all current and future clinical studies of brincidofovir for Ebola Virus Disease (EVD), including the study announced in December in Liberia sponsored by investigators at the University of Oxford and the supportive Phase 2 study of brincidofovir for EVD, Study 205.

Read more...
 

Corium to Present at the 2015 Leerink Global Healthcare Conference

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 07:55

MENLO PARK, Calif.--Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple, Corium's President and Chief Executive Officer, will present at the 2015 Leerink Global Healthcare Conference, Wednesday, February 11, 2015 at the Waldorf Astoria New York hotel. 

Read more...
 

Lydall Announces Divestiture of Charter Medical

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 06:41

MANCHESTER, Conn.--LYDALL, INC. (NYSE:LDL) announced today that it has completed the sale of Charter Medical, Ltd. ("Charter Medical"), a leading designer and manufacturer of specialty single-use products utilized in blood management, blood filtration and biopharmaceutical applications for the collection, processing, and storage of biological fluids.

Read more...
 

Quotient Limited to Report Third Quarter Fiscal 2015 Financial Results and Host Conference Call

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 03:13

JERSEY, Channel Islands--Quotient Limited ("Quotient") (Nasdaq:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ending December 31, 2014 will be released after market close on Monday, February 2nd, 2015.

Read more...
 

Martha MacCallum to Join SoldierSocks Advisory Board

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 03:10

Stamford, CT--The SoldierSocks Advisory Board provides counsel on ways to better serve and assist members of the U.S. Armed Forces. In addition to Ms. MacCallum, the Advisory Board is comprised of former United States Senator Joseph Lieberman, Philanthropist John H. Linnartz, Former CEO Linda McMahon, Special Advisor to former Joint Chiefs of Staff and Secretary of State General Colin Powell, Colonel Bill Smullen, Dr. Kathleen H. Hicks and Retired Vice Admiral Bob Murrett.

Read more...
 

Calithera Biosciences Appoints Keith Orford, M.D., Ph.D. to Vice President of Clinical Development

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 03:00

SOUTH SAN FRANCISCO, Calif.--Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, announced today the appointment of Dr. Keith Orford, M.D. Ph.D., as Vice President of Clinical Development.

Read more...
 

Lipocine Announces Presentation of LPCN 1107 Clinical Data at the Society for Maternal-Fetal Medicine 35th Annual Meeting

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 03:00

SALT LAKE CITY--Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, today announced that data from a successful Phase 1 study of LPCN 1107, the company's oral hydroxyprogesterone caproate ("HPC") product candidate will be presented at the Society for Maternal-Fetal Medicine 35th Annual Meeting in San Diego, CA.

Read more...
 

Onconova Therapeutics, Inc. to Present at Upcoming Investor Conferences in February

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 03:00

NEWTOWN, Pa.--Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced its participation in two investor conferences in February:

Read more...
 

Prosensa Announces Intent to Voluntarily Delist From NASDAQ

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 02:30

LEIDEN, The Netherlands--Prosensa Holding N.V. (Nasdaq:RNA) ("Prosensa" or the "Company"), the biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, announced today that it intends to voluntarily delist the registered shares of the Company, nominal value €0.01 per share (the "Shares"), from the NASDAQ Global Select Market ("NASDAQ").

Read more...
 

Stemline Therapeutics Announces SL-701 Granted Orphan Drug Designation for the Treatment of Glioma

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 02:30

NEW YORK--Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics targeting cancer stem cells (CSCs) and tumor bulk, announced today that SL-701 has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of glioma.

Read more...
 

Medgenics to Host Conference Call to Announce Fourth Quarter and Full Year 2014 Results on February 13, 2015

Print E-mail
By GLOBE NEWSWIRE   
Friday, 30 January 2015 02:30

PHILADELPHIA--Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Friday, February 13, 2015 at 8:30 a.m. ET to discuss fourth quarter and full year 2014 financial results.

Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 592

Newsletter